tackle
The National Federation of Prostate Cancer Support Groups
Report of 01ctorS and Financial statements
for period ending 315t December 2024
prostate cancer
THE NATIONAL FEDERATION OF PROSTATE
CANCER SUPPORT GROUPS
REPORT OF DIRECTORS AND FINANCIAL
STATEMENTS
FOR THE PERIOD ENDING
31ST DECEMBER 2024
Reglstered Charlty No (England & Wales): 1163152
A company limited by guarantee. Registered in England & Wales: 9672970
Registered oifice: Todmorden College, Burnley Road, Todmorden, OL14 7BX
The National Federation of Prostate Cancer Support Groups Report of Directors and Financial statements for period ending 31st December 2024
## **Board of Directors**
## **List of all Directors serving in 2024:**
Stephen Allen Appointed February 2022, Resigned June 2024 Aidan Adkins, Appointed February 2022, Resigned June 2024 Frank Chinegwundoh MBE Appointed February 2022 Anthony Collier BEM Appointed March 2023 Peter Corbishley Appointed March 2023 Angela Jones, Finance Director Appointed December 2022 Kyriakos Mastris Appointed March 2023 Roshani Perera, Chair Appointed March 2020 Shievon Smith Appointed September 2024 Joseph Hill Appointed September 2024 Paul Davies Appointed June 2024 Gary Eloket Appointed June 2024 Dave Wardell Appointed June 2024
## **Charity Registration Number 1163152 Company Registration Number 9672970**
## **Registered Office**
Todmorden College, Burnley Road, Todmorden, OL14 7BX
## **Independent Examiners**
TGFP Fulford House Newbold Terrace Leamington Spa CV32 4EA
## **Bankers**
Nat West Liverpool Street Station (B) Branch, PO Box 282, Bishopsgate, London EC2M 4QB
2
tackle
The National Federation of Prostate Cancer Support Groups
Report of Directors and Financial ststements
for period ending 31st December 2024
prostate cancer
The Trustees are pleased to present th8ir annual directors, report togeth8r with the financial
statements of the charity for the year ended 31 December 2024 whiGh are also prepared to
meet the requirem8nts for a directors. report and accounts for Companies Act purposes.
The financial statements follow th8 Charities Act 2011. the Companies Act 2006. the
charity's Memorandum and Articles of Association, and the Statement of Recommended
Practice- Accounting and Reporting by Charities appli¢able to charitl8s preparing their
a¢¢ounts by the Financial Reporting Standard applicable in the UK and Ireland (FRS 102)
(effective 1 January 2015).
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing Document
The National Federation of Prostste Cancer Support Groups (operating under the name:
Tackle Prostate Cancer) is a charitable company limited by guarantee. incorporated on 6
July 2015, and registered as a charity on 14 August 2015. On 1 January 2016. Th& National
Federation of Prostate Cancer Support Groups acquired the whole of the assels and
liabilities of the unincorporated association Prostate Cancer Support Federation (PCSF).
PCSF had been fomied in September 2007 and was dissolved in February 2016. The
company was set up under a Memorandum and Articles of Association (Articles) which set
up the objects, powers, and governance of the company. These Articles wer8 r8vised and
adopted by special resolution on 6 February 2023.
Re¢ruitmont, induction, and training of Directors (Trustees)
The Board consists of not less than three nor more than ten Directors made up as follows..
Up to seven Directors being members of member organisations and el8Ct8d by the
members at the Annual General Meeting
Up to three Directors appointed by the Board who have a specifiG expertise e.g..
finance, HR or marketing.. and
The Directors shall appoint one of their number as Chair and may detemiine the
length of lerm to serve in that office. The Directors may also appoint one of thoir
number as vic8-chair.
Directors are also Trustees of th8 charity and govem the activities of the Charity as a Board.
Upon appointment lo the Board. to help ease their understanding of the current issues
concerning the organisation, each new Director is provided with a copy of the Charity
Commission publication entilled 'The Essential Trustee-. What you need to know" which
gives guidance on what is expected of them. New Directors are also provided with briefings
from the Chair on th8 Structure. strategy and operations of the charity. The Board meets four
times a year army devolves responsibility for overseeing the day-to-day running of the
organisation to the executive team curr8ntly led by Sarah Gray and overseen by the Chair
and Vice-chair. Sub-committees with Trustee representation is in pla to govern specific
adivities such as fundraising, marketing. appointments and remuneration.
The purpose of the charlty
The charity is a federalion, whose member organisations (-members") are patient-led
prostate canr support groups. The purpose of the charity is to c¢>ordinate, fo¢us and
tackle
The National Federation of Pr95tate Cancer Support Groups
Report of Dirertors and Financial statements
for period ending 31st December 2024
prostate cancer
Objectivos arKI activities for the public benefit
As sel out in its governing document. the objects of the charity are to relieve the sickness.
physical and mental distress of persons affected by prostste cancer in th8 UK. but not
exclusively by..
assisting and strengthening the activtties in support of people affected by prostate
cancer. including encouraging and supporting the formation of new local prostate
support organisations throughout the UK
encouraging the improvement of health services available to prostate ¢anor
patients; and
acting as a focus for and expr8ssing the views of patient-led support groups
conceming
a. raising awareness of prostste canr
improving the health services available to prostate cancer patients., and
c. priorities for research into the diagnosis and treatment of prostste nCer.
Our vision is to be the 'go to, d)arity for peer support and our mission is To enable th6
growth of peer support groups across the country. ensuring the n88ds of people living with
and impacted by proslate cancer are met, and their voices are heard.
Our strategic imperatives as sel out in our 3-year plan (2023-20261 are to:
Grow and strengthen our relationships and repulation amongst peer support
group$
Recognise and amplify the importan¢e of tha usar voico across tho health and
social care system
Demonstrate our impact and value to the prostate cancer communty and
general public
Secure financial sustainability through an effective fundraising strategy
Ensure we have robust organisational governance to deliver our strategy and
mandatory requirements
Achievements In 2024
We continued our mission to become the 'go to, charity for peer support by investing in th8
people who lead our groups. This year, we launched Best Practice Guidelines, built a more
user-friendly Members, Portal. and mainlained a sleady rhythm of monthly briefings. Zoom
meetings. and in-person visits to support our leaders.
We delivered 30 face-to-face group visits and facilitated regular group leader forums
attended by an averag8 of 35 leaders per session. More than 60% of 8UPPOrt groups now
use the Members, Portal.
We are working to encourage and support the take up of our Best Practice Guidance. which
was launched in April 2024- a sel of principles to ensure good g0veMan of our member
support groups.
Recognising the powerful influence of real-life stories, we launched the 'Many FaS of
Prostate Cancer, campaign, a follow-up to the successful 'L8t's Talk About IY series. These
short films aim to share the real-life experieeS of people from diverse backgrounds and
communf(ies.
tackle
The National Federation of Prostate Cancer Support Groups
Report of Directors and Financial statements
for period ending 31st December 2024
prostate cancer
We also scaled up our digital engagement. Website visitors grew by 44%, and social media
engagement rose by over 90¥0.
Working in partnership with other charities in the cancer community. Tackle has remained at
the forefront of national campaigns. As partners in campaigns suth as Boys Need Bins, our
supporters advocated for changes in their localities, including the installalion of sanitary bins
in male cubicles across Lancashire and Herefordshiré.
We are working in partn8rship with Prostate Cancer Research and others to advocate for
target8d scre8ning for high-risk eK)mmunities through the Proactive for your Prostate
campaign. Members of our board and staff have been active in lobbying MPS at iwo Palace
of Westminster events.
We continue lo lobby for better diagnosis, treatment. and services as part of The One
Cancer Voice campaign.
2024 saw the launch of 7 new groups. bringing our n81work to 140. We introduced groups in
underserved areas and activily-based models. The Peer Coaohing Programme, now funded
by Movember, began its rollout with the first'Train the Trainerf s6ssions.
We also ernbedded equity, diversity. and inclusion principles through new partnerships and
ongoing training
Looking Ahead
We have built strong foundations with our National Lottery and Movember funded projects.
and our upcoming work will focus on:
Expanding and piloting the Peer Coaching model
Growing our network of groups in Yorkshire and the Northeast and across the
Midlands, wlth a particular focus on ensuring we meet the needs of underserved
communities.
Growing our community fundraising
Ensuring our nelwork of Group Leaders and organisers have the tools, krtowledge,
and skills to run welcoming. effective, safe and well-governed support groups and
Participate in national campaigns.
tackle
The National Federation of Prostate Cancer Support Groups
Report of Dirertors and Financial statements
for period ending 31st December 2024
prostate cancer
FINANCIAL REVIEW
Flnancial Perforniance
Our income this year at £179,228 was an incr88se of 459h on 2023. Our expenditure of
£201,790 was up by 31°k overall, with charitable expenditure increased by 24°/o. W8 finished
the year with a deficit of £22,561.
As recognised by the Board in their risk assessment, fundraising contlnu8S to b8 a serious
challenge for the Charity. We are extremely grateful to all our members and supporters for
their generosity in donating funds to COV8r th8 work that we do to support prostate cancer
patienls and their families. In line with ABPI guidelines, we continued to benefit from financial
support from phamiaceutical companies, some of whom we work closely with as patient
advocates.
Reserves Policy
In line with the guidance issued by the Charity Commission. the Trustees have considered
the future n8eds of the charity and believe that unrestricted general funds, that is funds
which are neither restricted nor desnated, should be at least three months, forward
operating expenditure. Such funds are needed to safeguard the charity's aGtivity against an
unexpected shortfall in fundraising income, emergency, or unforeseen expenditure and to
ensure its financial slability over the longer term.
Statement of Trustees. Responsibilities
The Trustees (who are also the Directors of th8 charitable company for th8 purposes of
company law) handle preparing the Annual Report and financial statements following
applicable laws and United Kingdom Generally Accepted Accounting Practice.
Company law requires the charity trustees to pr8pare financial statements for each year
which give a true and fair view of the situation of the charitable company and of the incoming
re$our¢es and appli¢ation of resources induding the income and expenditure of the
charitable company for Ihat pericd. In preparing those financial statefflents, the ttustees
must..
select suitable accounting policies and then apply them consistentty.
observe the methods and principles in the Charity SORP 2015 (FRS 102).
make judgements and estimates that are reasonable and prudent.
state whether applicable accounting standards have been followed; and
prepare the financial statements on the going concem basis unless it Inappropriate to
presume that the chariiable wmpany will continue in business.
The trustees handle keeping prop6r accounting records which show with reasonable
accuracy at any time the financial position of the charitable company and to enable them to
ensure that the financial statements follow the Companies Act 2006. Th8y are also
responsible for safeguarding the assets of the charitable company and hence for taking
reasonable steps for the prevenkn'on and detection of fraud and other irregularities.
The trustees handle the maintenance and integrity of the corporate and financial information
included on the tharitable company website. Legislation in the United Kingdom governing
the preparation and dissemination of financial statements may differ from legislation in other
jurisdictions.
tackle
The National Federation of Prostate Cancer Support Groups
Report of Direttors and Financial statements
for period ending 31st DeMber2O24
prostate cancer
This report was approv8d by the Board of Trustees and signed on its behalf by:
Roshani Perera
Roshani Perera
The National Federation of ProS&e Cancer Support Groups
(operating as Tacklo Prostate Cancer)
Independent Examinerfs Report to the Trustees of
The National Federation of Proststs Cancer Support Groups
I report lo the charity trustees on rny examination of the accounts of the company for Ihe year
ended 31 December 2024. which are set out on pages 10 to 17.
Rosponsibilities and basis of report
As the charity trusteés of the company land also its directors for the purposes of company
law) you are responsible for the preparation of the accounts in a¢cordanc8 with the
requirements of the Companies Act 2006 ('the 2006 Act.).
Having satisfied myself thal the accounts of the company are not required to be audited
under Part 16 of the 2006 Act and are eligible for independent examination. I report in
respect of my examination of your company's accounts as carried out under section 145 of
the Charities Act 2011 ('the 2011 Aot,). In carrying out my examination I have folbwed the
Directions given by the Charity Commission under section 145(5){b) of the 2011 Act.
Basis of independent examinefs report
My examination was carried out Sn accordance wlth the general Directions given by thè Charity
Commission. An examination includes a review of the accounting records kept by the charity and a
comparison of the accounts presented with those records. It also includes consideration of any
unusual items or disclosures in the accounts and seeking explanations from you as trustees
cOnrning any such matters. The procedures undertaken do not provid8 all the evidenGe that
would be required in an audit and consequentjy no opinion is given as lo whelher the accounts
presènt a 'tru8 and fair view, and the report is limited to those matters set out in the statemgnt
below.
Indepond8nt examiner's statement
I confimi that l am qualified to und8rtak8 the examination because l am a member of Ihè Institute
of Chartered Accountants in England and Wales. I have completed my examination. I confimi that
no matters have come to my attèntion in connection with the examination giving me cause to
believe that In any mat8rial r8SP6Ct'.
accounting records were not kept in respect of the company as required by sectlon 386 of
the 2006 Act., or
2. the accounts do not accord with those records., or
3. the accounts do not comply with the accounting requirements of section 396 of the 2006
Act other than any requirement that the accounts give a 'true and fair view, which is not a
matter considered as part of an independent examination., or
4. the accounts have not been prepared in accordan with the methods and principles of the
ststement of Recommended Pra¢tice for accounting and reporting by charities {applicabl8
to charities preparing their accounts in accordan with the Financial Reporting Standard
applicable in the UK and Republic of Ireland {FRS 102)-
Tho National Federation of Prostatè Cancer Support Groups
(operating as Tackle Prostate Cancer)
Independent Examiner's Report to the Trustees of
Tho National Fèderation of Prostate Cancer Support Groups - continuod
I have no concerns and have come across no other matters in connection with the examination to
which attention should be drawn in this report in order to enable a proper understanding of th8
accounts to be reached.
BENJAMIN R REYNOLDS Bsc (Hons) FCA.
TGFP
Chartered Accountants & Statutory Auditors
Fulford House
Newbold Terrace
Leamington Spa
CV32 4EA
Date: 2310412025
The National Federation of Prostate Cancer Support Groups
(operatlng as Tackle Prostate Cancèr)
Statement of Financlal Activities
for the year ended 31 December 2024
INCOME AND EXPENDITURE
Unreslrictsd
Funds
Restricted
Funds
Tolal
2024
Total
2023
Note
Incomlng Rosour¢&s
Voluntary income
Investment income
76,255
595
102.378
178.633
595
122.7C
667
Total Income
76.850
102,378
179,228
123,367
Expondlturé on:
Raising funds
Charitable activities
25.049
90,071
103
86,566
25.152
176,637
11.867
142,469
Totsl Expenditure
115,120
86,669
201,789
154,336
Net Incomel{Expondilure)
(38.270)
15.709
(22.561)
(30,969)
Net Movement In Funds for tho Year
38.270)
15.709
(22,561)
30,9)
Reconciliation of Funds
Total funds blf at 1 Jan 2024
115,035
49,057
164.092
195,060
Funds Transfer
7.269
(7.269)
Totsl fund5 Gtt at 31 t)ec 2024
10
The statemenl of finan¢ial adivitie5 inGludes all gains and losse5 recognised in tho year. All income and
expenditure deriv85 from continuing activities.
Pag8= 10
## **The National Federation of Prostate Cancer Support Groups (operating as Tackle Prostate Cancer) Statement of Net Assets As At December 2024**
|Note
**Fixed Assets**
**Current Assets**
Debtors
7
Cash at bank and in hand
**Creditors: Amounts falling due**
**within one year**
8
**Net Current Assets**
**Net Assets**
**Represented by:**
Restricted Funds
10
General Unrestricted Funds
10
Designated Funds
10
**Total Funds**|**2024**
**£**
-
**20,155**
**214,560**
**234,715**
**93,184**
**141,531**
**141,531**
**57,497**
**59,034**
**25,000**
**84,034**
**141,531**|2023
£
-
11,865
157,848|
|---|---|---|
|||169,713
5,621|
|||164,092|
|||164,092|
|||49,057
90,035
25,000|
|||115,035
164,092|
The notes on pages 15 to 21 form part of these financial statements.
The charitable company is entitled to exemption under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.
The directors have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for:
- (a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
- (b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to the financial statements, so far as applicable to the charitable company.
These financial statements have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to charitable small companies. The financial statements were approved by the Board on …......1st July 2025 and signed on its behalf by:
## Roshani Perera
Anthony F C Collier
Chamintha Roshani Perera Chairman
Anthony Collier BEM Finance Director
Page: 11
The National Federation of Prostate Cancer Support Groups
(operating as Tackle Prostate Cancer)
Note to the Financial Statements (Cont.)
for tha year ended 31 December 2024
Accountlng Policies (continued)
Operating l•as•s
Rentals payable under operating leases are charged against income on a straight line basis over
the18as8 term.
g. Financial Instruments
Basic financial assets, which include cash and bank balans, are initially measured at transaction
price including transaction costs and are subsequenlly carried at amortised cost using the effective
interest method unless the arrangement constitutes a financing transaction. where the transaction
is measured at th8 pr8sent value of the future receipts discounted at a market rate of interest.
Financial assets classified as receivable within one year are not amortised.
h. Funds
General lunds - thesè are unrestricted funds which can be used for the charitable objects at th6
discretion of the Trustees and which have not been designated for other purposes.
Rèstrict8d funds - these are funés that Can only be used for particular restricted purpos8S Wlthin
the objects of the charity- Restrictions arise when speGified by the donor or when funds are raised
for particular restricted purpos8s. The aim and use of each restricted fund is set out in the not6s to
the financial statements.
Deslgnated funds - these are UnstriCted funds which have been set aside by th8 Trustees for
specific purposes. The aim and use of 6ach designated fund is set out in the notes to the financial
statements.
Interest recelvable
Interest on funds held on deposit is included when receivable- this is nomally upon receipt or upon
notification of the interest paid by the Bank or Building Society.
P8nsion costs
The Charity operates a defined contribution stakeholder pension scheme. The amount charged to
the statemenl of financial activities in respect of pension costs is the Charity's contributions payable
in the year. The assèts of th8 scheme are held separately from the Charity. There was no
outstanding liability owed to the scheme at the end of the currenl or prior years.
k. Employee Benefits
The cost of short-term employee benefits are recognised as a liability and an expense. The cost of
any material unused holiday entitlement is recognised in the period in which the employee's
seNices are received.
Page.. 12
The National Federation of Prostate Cancer Support Groups
(operating as Tackle Prostate Cancer)
Note to the Financial Statements (Cont.)
for the year ended 31 December 2024
2 Voluntsry Income
Unrestricted
2024
Restricted
2024
Total
2024
Total
2023
Donations received from..
Members
Individuals and Community
Trusts and Foundations
Companies
13,307
32,718
30.230
13,307
135,096
30.230
10,717
73.583
38.400
102,378
102,378
178 633
122.700
Of which in 2023:
Unrestricted
Restricted
74.067
48.633
122.700
For a breakdown of prior year comparatives. see not8 12
3 Fundraislng Activities
Unrestricted
2024
Restricted
2024
Total
2024
Total
2023
Fundraising Costs
Support Costs
Govemance Costs
25.049
103
25,152
11,867
103
25,152
11,867
Of whlch In 2023:
Unrestricted
Restricted
11,867
For a breakdown of prior year comparatives. see note 12
4 Charitable Activities
Note
Unrestricted
2024
Restricted
2024
Total
2024
Tolal
2023
Campaigning & Awareness
Groups Support
Staff Costs
Support Costs
Govemance Costs
14,487
4,352
33,020
21.330
16,882
6,343
6,274
48,571
17.704
7,674
20,830
10,626
81,591
39,034
24,556
19,938
23,728
63,657
29,371
15,775
90,071
86,566
176 637
142,469
Of which in 2023:
Unrestricted
Restricted
54,701
87,768
142 469
For a breakdown of prior year comparatlV8S. See note 12
Page: 13
The National Federation of Prostate Cancer Support Groups
(operating as Tackle Prostate Cancer)
Notes to the Flnancial Statements (Cont.)
for the year ended 31 December 2024
5 Support and Governance Costs
Support Govarnance
Costs
Costs
Total
2024
Total
2023
other Costs
Bank Charges
Trustee Meetings and Expenses
Audit
Legal & Professional Fees
37,780
58
1.196
23,801
61,581
58
1.479
40.853
72
3.488
283
472
472
733
39.034
24.556
45,146
Basls of
AllotIOn
0.00
100.0°/
Allocated to fundraising costs
AlloGated to Gharitablg activitles
39.034
24.556
63,590
100.00
6 Staff Costs
2024
2023
Salaries and wages
Social security costs
Pension contributions
Recruitment
Training
71060
2.570
1,759
1.202
52.481
310
429
438
Total 8mploy88 cosls
53,658
No employee eamed in excess of £60,000 p.a.
The key management personnel of the Charity are the Trustees who do not receive remuneration
but during the year the charity paid aggregale expenses tolalling £1,479 (2023.. £3,488) relating to
512023.. 9) trustees in respect of travel, accommodation and subsistence.
The charity includes Trustees. Liability Insuran in its combined Insuran policy.
The average number of employees (headcount based on number of staff employed) during the
year was as follows..
2024
2023
Engagement
7 Debtors
2024
2023
Other debtors
Prepayments
15,289
4,866
11.250
615
11,865
Page.. 14
The National Federation of Prostate Cancer Support Groups
{operating as Tackle Prostate Cancer)
Notes to the Financial Statements (Cont.)
for the year ended 31 December 2024
8 Creditors: amounts falling due within onè ar
2024
2023
Trade creditOT5
Taxation and Social Security
Accruals
other Credltors
Deferred Income
5409
1,828
2.632
1,028
133
1028
133
81927
9 Analysis of Net As$ets between Funds
Unrestricted Restricted
Funds
Funds
Total
Funds
Total assets
Current liabilities
Net Assets at 31 Dec 2024
177,218
93,184
57,497
234,715
193,184)
141 531
For a breakdown of prior year compardtives, se8 note 12
10 Movements In Funds
1Jan
Incomlng
2024 Resources
Outgoing
Resources
Fund
Transfers
31 Dec
2024
Unrestricted Funds:
General
Designated - Development Fund
90,035
25,000
76.850
(115,120)
7,269
59,034
25,000
Total Unrestricted Funds
115,035
76,850
(115.120)
7,269
84,034
Re8trlctod Funds:
Tackle Man Van
National Lottery Community
Fund
Tackling Prostate Cancer- peer to
peer suppcvl for m6n wolh prost8te
cancer
Other restricted funds
2,500
12,500)
14.596
31,961
95.378
7,0(Kl
(62,033)
(24,636)
47,941
9,556
{4.7691
Tolal Restricted Funds
49.057
102,378
86,669
{7.2691
57,497
Total Funds
164,092
179,228
201,789
141.531
For a breakdown of prior year comparatives, see note 12
Pagg.. 15
The National Federation of Prostate Cancer Support Groups
(operating as Tackle Prostate Cancer)
Notes to the Financial Statements {Cont.)
for the year ended 31 December 2024
12 Comparative Nots Only
Not8 2 - Voluntary Income
2023
Total
Unrestricted
Restricted
Donations rnceived from."
Members
Individuals and Community
TNsts and Foundations
Companies
10,717
24,950
38,400
10,717
73,583
38,400
48.633
74,067
48,633
122.700
Note 3 - Fundraising Activities
2023
Total
Unrestricted
Restricted
Fundraising Costs
Support Costs
Govemance Costs
11.867
11,867
Note 4 - Charitable Activities
2023
Total
Unrestricted
Restricted
Campaigning & Awareness
Groups Support
Staff Costs
Support Costs
Govemance Costs
13,236
3.153
6.003
17,126
15,183
6,702
20.575
47.654
12.245
592
19,938
23,728
53,657
29,371
15,775
54,701
87.768
142 469
Note 9 - Analysis of N•t Assets between Funds
Unrestrlcted
Funds
2023
Total
Funds
Restrlcted
Funds
Total assels
Current liabilities
Net Assets at 31 Dec 2023
120,655
(5.621)
115,034
49.057
169,712
{5,621}
164,091
Page: 16
The Natlonal Federation of Prostate Cancer Support Groups
(operating as Tackle Prostate Cancer)
Notes to the Financial Statements (Cont.)
for the year ended 31 December 2024
12 Comparatlve Note Only (Gontinued)
Note 10 - Movements in Funds
1Jan
Incoming
Outgolng
2023 Resources Resourcès
Fund
Transfers
31 Dec
2023
Unreslricted Funds:
General
Designated - Development Fund
81,867
25,OC
74,734
166,567)
90,034
25,000
Total Unrestricted Funds
106,867
74,734
(66,567)
115,034
Restricted Funds:
Ta¢kle Man Van
National Lottery Community
Fund
Tackling Pfostale Cancer- poerto
peer support for men wlh prostste
cancer
Other restricted funds
2,5(M)
55.936
29.757
41.633
7,000
(82,973)
(4,796)
14,596
31,961
Totsl Restrlcted Funds
88,193
48.633
87,769
49,057
Total Funds
195 060
123367
154 336
Page:17